Call 413.540.1234 to
schedule an appointment
CONCERN/EAP: 413.534.2625
Billing questions? Call: 413.540.1212
CRISIS: 413.733.6661

Health Policy & Advocacy
Resources
Basic InformationMore InformationLatest News
FDA Warns of Deaths Tied to Tainted Synthetic PotWhere Are Opioid Painkillers Prescribed the Most?In the ICU, Patients' Relatives Often Mum About Care ConcernsResetting E-Prescriptions for Opioids Helps Curb Use: StudyHealth Tip: If You're 45 or Older, Get Screened for Colorectal CancerRed Cross Issues Nationwide Call for Blood DonationsDoctor Burnout Widespread, Helps Drive Many Medical ErrorsWarming Climate, More AC -- and More Unhealthy Smog AheadEven at 'Safe' Levels, Air Pollution May Boost Diabetes RiskDeath Certificate Data May Miss Many Opioid ODs: StudyRaise the Bar on CPR, Heart Group SaysWhen DEA Cracked Down on Opioids, Abusers Moved to Black Market: StudyStigma of Safe Needle Exchanges Lingers Despite Opioid EpidemicAHA: Drones a Lifesaver for Cardiac Arrest Patients?Millions Die Worldwide Each Year for Lack of Quality CareTips for Handling a Medical EmergencyAHA: Lifesaving Info Not Always a 911 Call AwayMany, But Not All, Hospitals Require Flu Shots for StaffersCancer Care Twice as Costly in U.S. Versus CanadaAHA: Health Concerns Haunt Puerto Rico as New Hurricane Season BeginsPot, Opioids Now Rival Alcohol as Factor in Driver DeathsThe ER or Urgent Care?Trumps Signs Bill Allowing Terminal Patients to Try Unproven MedicinesTough State Drunk Driving Laws Save LivesE-Cigarettes Don't Help Smokers Quit, But Cash MightSmall World? Not With One-Quarter Obese by 2045A Pill to Protect You From the Sun? Don't Believe It, FDA SaysMost Hospitals Aren't Ready for Mass Tragedies, ER Docs SayAHA: Making America's Doctors Look More Like AmericaLanguage Used in Medical Record Can Affect Patient CareNonprofit Manufacturer Could Keep Generic Drug Costs DownOpioid Makers' Perks to Docs Tied to More PrescriptionsFDA Targets Clinics Offering Unapproved Stem Cell TherapiesLittle 'Quit-Smoking' Help at U.S. Mental Health CentersIs Testing for Zika in U.S. Blood Supply Worth the Cost?'Smoke-Free' Rooms Still Loaded With Smoke Residues, Study FindsAHA: Smoke-Free Laws Do Seem to Help Young Adults' HeartsAHA: Poverty Levels Key to States' Performance on Heart DiseaseSimple Drug Packaging Change Could Save Toddlers' LivesFDA Cracks Down on Dangerous E-Cig Liquids That Resemble Cookies, CandyNew Clinic Satisfaction Tool Provides Real-Time FeedbackUnused Meds? Saturday Is National Drug Take Back DayA Doctor's Age May Matter With Emergency SurgeryPatients Prefer Doctors Who Engage in Face-to-Face VisitsU.S. Better Able to Tackle Health Emergencies: ReportFirst Opioid Lawsuit Targeting Pharmacy Benefit ManagersMost Doctors' Offices Don't Offer Flexibility for UninsuredSafety Info for Opioids Found LackingNonoptimized Drug Therapy Costs More Than $500 Billion AnnuallyFDA Cracks Down on Caffeine-Loaded Supplements
Questions and AnswersLinksBook Reviews
Related Topics

New Research Debunks Two Medical Marijuana Myths

HealthDay News
by By Alan Mozes
HealthDay Reporter
Updated: Feb 22nd 2018

new article illustration

THURSDAY, Feb. 22, 2018 (HealthDay News) -- Mention legalizing medical marijuana, and people often think two things:

  • This will prompt teens to think marijuana use is OK, and more will start using it.
  • Legalizing marijuana will reduce the number of adults overdosing on opioids.

As it turns out, neither has proven to be true, according to new research.

Since medical marijuana first became legal in California in 1996, it's been legalized across nearly three-fifths of the United States. However, that's had virtually no impact on the rate of recreational marijuana use among teens, a broad review of published studies has found.

"Several years ago, before the group of papers we [analyzed] started to be published, people thought that medical marijuana laws would increase teen marijuana laws by 'sending the message' to teens that marijuana was safe and acceptable to use," explained Deborah Hasin, the new study's lead author.

However, she said, "it doesn't seem that teens were impacted much by this -- perhaps because they didn't find the legalization of medical use very relevant to them or didn't even know about the laws."

Hasin is a professor of epidemiology at Columbia University's College of Physicians and Surgeons in New York City.

The impact of marijuana legalization also has been minimal on the risk for fatal overdosing among adult users of opioid pain medications, a separate study team has found.

On the opioid link, American, Australian and British researchers found little to suggest that increased access to medical marijuana as an alternative way to manage chronic pain has led to any measurable drop in deaths from opioid abuse.

In fact, lead author Wayne Hall warned that research suggesting any substantive link between the two is "weak." He is a professor with the Center for Youth Substance Abuse Research at the University of Queensland in Brisbane, Australia.

Hall and his colleagues caution that "it is premature to recommend the expansion of access to medical cannabis as a policy to reduce opioid overdose risks in the United States and Canada."

Though the chances of overdosing on marijuana are low, the drug has been shown to have only a "modest" effect for pain control, according to the researchers.

"There are much better treatments [than marijuana] that have been shown to reduce [opioid] overdose deaths that are not currently being widely used in the U.S.A.," Hall said. "Foremost among these is medication-assisted treatment, using methadone or buprenorphine."

Despite the findings of both research teams, legalizing medical marijuana is not consequence-free, Hasin said.

"Passing laws legalizing marijuana use has some social benefits -- business and tax revenues, job creation, and reduction in unfair race-based arrests," she said.

"And while not every marijuana user experiences harms, using marijuana does have some risks, including withdrawal, addiction and increased chances of vehicle crashes," Hasin said.

The results of both studies are published online Feb. 22 in the journal Addiction.

Paul Armentano, deputy director of NORML, the marijuana information and advocacy organization, said he was "hardly surprised by the results" of the finding regarding use among youth.

Dozens of studies, he said, "affirm that regulating either adult marijuana use or medical purposes is not associated with any significant uptick in either youth use, access, problematic use or drug treatment admissions.

"The data is clear and consistent on these issues, and those opining to the contrary are either willfully ignorant or woefully ignorant of the relevant science," Armentano said.

More information

The U.S. National Center for Complementary and Integrative Health has more on medical marijuana.